Showing 1,341 - 1,360 results of 2,406 for search '"SARS"', query time: 0.08s Refine Results
  1. 1341

    Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein by Marie-Lynn Cuypers, Tom Jaspers, Jarne Clerckx, Simon Leekens, Christopher Cawthorne, Guy Bormans, Frederik Cleeren, Nick Geukens, Bart De Strooper, Maarten Dewilde

    Published 2025-01-01
    “…Results Additional binding to MOG increases the Cmax and brain half-life of antibodies that are actively shuttled over the BBB. Anti-SARS-CoV-2 antibodies coupled with an anti-TfR VHH and two low affinity anti-MOG VHHs could be detected in brain 49 days after a single intravenous injection, which is a major improvement compared to an anti-SARS-CoV-2 antibody fused to an anti-TfR VHH which cannot be detected in brain anymore one week post treatment. …”
    Get full text
    Article
  2. 1342

    Neurological damages in COVID‐19 patients: Mechanisms and preventive interventions by Sibani Sarkar, Subhajit Karmakar, Malini Basu, Pratyasha Ghosh, Mrinal K Ghosh

    Published 2023-04-01
    “…Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a novel coronavirus, causes coronavirus disease 2019 (COVID‐19) which led to neurological damage and increased mortality worldwide in its second and third waves. …”
    Get full text
    Article
  3. 1343

    Risk Predictors for Mortality in Inpatients with Cancer and Coronavirus Disease 2019 during the Omicron Wave by Kuan-Yu Chen, Chih-Cheng Lai, Chien-Tai Huang, Yin-Hsun Feng

    Published 2023-10-01
    “…We analyzed the characteristics and risk factors for mortality in hospitalized patients with cancer and laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the Omicron wave. Materials and Methods: We conducted a retrospective, single-center, cohort study of 206 patients with cancer and SARS-CoV-2 infection in southern Taiwan. …”
    Get full text
    Article
  4. 1344

    Post-COVID-19 patients’ clinical-epidemiological characteristics in Baracoa, Guantánamo by Yirleidy Rodríguez Labañino, Yodanky Ochoa Rodríguez, Alexander Durán Flores, Denny Matos Laffita, Oneidis Durán Flores

    Published 2023-05-01
    “…<br /><strong>Objective</strong>: to characterize, from the clinical and epidemiological point of view, patients confirmed to SARS-CoV-2 in the post-COVID-19 stage.<br /><strong>Methods</strong>: a descriptive cross-sectional study was carried out in patients confirmed to SARS-CoV-2 in the post-COVID-19 stage, belonging to the Hermanos Martínez Tamayo Polyclinic, from October to November 2021. …”
    Get full text
    Article
  5. 1345

    El COVID-19 y el papel del médico veterinario: Una sola salud, perspectivas y cambios para los expertos en salud. by Linda Guiliana Bautista Gómez, Ariadna Flores Ortega, Dra.

    Published 2025-01-01
    “…Es poco probable que el SARS-CoV-2 sea el último coronavirus en saltar la barrera de especies que infecta a humanos y otras especies animales. …”
    Get full text
    Article
  6. 1346

    Prevalence and Trajectory of COVID-19-Associated Hypercoagulability Using Serial Thromboelastography in a South African Population by Sarah Alexandra van Blydenstein, Colin Nigel Menezes, Nicole Miller, Naomi Johnson, Bavinash Pillay, Barry F. Jacobson, Shahed Omar

    Published 2021-01-01
    “…The coagulation abnormalities resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been attributed to inflammation and subsequent cytokine storm. …”
    Get full text
    Article
  7. 1347

    Discovering Associations: Kawasaki Disease and COVID-19 by Nicholas Peterson, Kaustubh Sagdeo, Donna Tyungu, Cristin Harper, Kyle Mihaylo, Elza Pollak-Christian

    Published 2020-01-01
    “…It has been theorized that children who are asymptomatic or who do not display significant respiratory symptoms are potential vectors for community transmission of the SARS-CoV-2 virus. This is incompletely understood due to the current lack of widespread testing in the pediatric population. …”
    Get full text
    Article
  8. 1348

    Determination of anti-COVID-19 IgG and IgM seroprevalence among pregnant women at Pietersburg Hospital, Limpopo Province, South Africa by I Rukasha, S T S Pheeha, M R Lekalakala, P Malope

    Published 2024-03-01
    “…To determine the seroprevalence of anti-SARS-CoV-2 antibodies among pregnant women attending an antenatal clinic. …”
    Get full text
    Article
  9. 1349

    Altered Protein Structures and Neoepitopes in Lupus Neutrophils From Dysregulated Splicing of Messenger RNA by Rayan Najjar, Xiaoxing Wang, Jose Mario Bello Pineda, Hugh Alessi, Alison Bays, Robert K. Bradley, James N. Jarvis, Tomas Mustelin

    Published 2025-01-01
    “…Only a small number of dysregulated splicing events were more pronounced in patients with active disease or with high type I interferons but were not detected in SARS‐CoV2–infected individuals, who also had high type I interferons. …”
    Get full text
    Article
  10. 1350

    Комплексний аналіз кореляції генотипу-фенотипу при діагностиці синдрому недиференційованої рецидивної гарячки в дітей... by O.R. Boyarchuk

    Published 2024-10-01
    “…Першому епізоду гарячки передувала інфекція SARS-CoV-2 із пневмонією, наступні епізоди - за 2-3 тижні після респіраторних інфекцій. …”
    Get full text
    Article
  11. 1351

    Reusable Biosensor for Easy RNA Detection from Unfiltered Saliva by Paweł Wityk, Agata Terebieniec, Robert Nowak, Jacek Łubiński, Martyna Mroczyńska-Szeląg, Tomasz Wityk, Dorota Kostrzewa-Nowak

    Published 2025-01-01
    “…During validation, the biosensor demonstrated a sensitivity and specificity of 100%, accurately identifying SARS-CoV-2 in saliva samples without false positives or negatives. …”
    Get full text
    Article
  12. 1352

    Seroprevalence of COVID-19 among voluntary blood donors by Arumugam Pothipillai, Swathandran Hamsavardhini, Deepa Duraisamy, Lincy Thiyagarajan, Chandrasekaran Kaliyaperumal, Jyotsnaa Grace Velure Mohan Rao

    Published 2024-01-01
    “…AIM: The main aim of this study is to assess the seroprevalence of SARS-CoV-2 antibodies among healthy and asymptomatic voluntary blood donors by enzyme-linked immunosorbent assay (ELISA). …”
    Get full text
    Article
  13. 1353

    Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective by Stefano Sanduzzi Zamparelli, Alessandro Sanduzzi Zamparelli, Marialuisa Bocchino

    Published 2025-01-01
    “…The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has profoundly impacted global health, with pneumonia emerging as a major complication in severe cases. …”
    Get full text
    Article
  14. 1354

    Occupational and non-occupational factors of post-COVID-19 condition: a cross-sectional survey in the French general working population by Joël Coste, Cyrille Delpierre, Tatjana T Makovski, Melissa Rushyizekera

    Published 2025-01-01
    “…Associations of occupational and non-occupational factors with PCC were tested in a conceptual model accounting for the relationships between these factors and considering two control groups (previously infected participants without PCC and participants with no reported or diagnosed SARS-CoV-2 infection). Interactions between occupational and non-occupational factors were considered.Results The survey included 1131 working adults. …”
    Get full text
    Article
  15. 1355

    Topic Modeling of Nursing Issues in the Media During 4 Emerging Infectious Disease Epidemics in South Korea: Descriptive Analysis by Jungok Kim, Eun Kyoung Yun

    Published 2025-01-01
    “…Using topic modeling, we derived 5 topics each for SARS, influenza A, and MERS and 6 topics for COVID-19. …”
    Get full text
    Article
  16. 1356

    Encefalopatía como forma de presentación de la COVID-19 by Jorge Félix Nuñez Martínez, Catherine Madruga Vásquez, Raity Hernández Fernandez, Guillermo Pérez Ciprián, Iliana Bouza Denis

    Published 2021-12-01
    “…Introducción: El virus SARS-CoV-2, responsable de la COVID-19 presenta una alta tasa de contagio y es capaz de producir afecciones a diferentes niveles en el organismo, e incluye el sistema nervioso central, con manifestaciones como crisis convulsiva febril y afebril, estado de mal epiléptico, encefalopatías y encefalitis. …”
    Get full text
    Article
  17. 1357

    Urine amino acid and gamma aminobutyric acid level in COVID 19 patients by Cemal Kazezoglu, Arzu İrvem, Yasemin Tuba Sutasir, Büşra Çakiroglu, Banu Kirgiz, Habip Yilmaz, Ali Kocatas

    Published 2025-02-01
    “… Background and Objectives: SARS CoV2 has tropism for various tissues, including the respiratory tract, brain, endothelium, heart, kidney and liver. …”
    Get full text
    Article
  18. 1358

    COVID-19, Influenza and Economic Activity — An Impact Analysis Perspective by Adalbert Winkler

    Published 2020-05-01
    “…Abstract The German debate about the policy implications of the coronavirus becomes increasingly heated given different views on the mortality rate from SARS CoV-2, as well as the epidemiological and economic impact of lockdown measures imposed by the government. …”
    Get full text
    Article
  19. 1359

    Investigating Viral Inoculation and Recovery from Medical Masks by Mark C. Wilkinson, Jennifer Carney

    Published 2022-01-01
    “…The SARS-CoV-2 pandemic from 2019 onwards has significantly increased the usage of surgical style medical masks, both in healthcare and public settings. …”
    Get full text
    Article
  20. 1360